Aquilo Capital Management

Latest statistics and disclosures from Aquilo Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are XBI, IWM, SPRO, BPMC, DRNA, and represent 85.86% of Aquilo Capital Management's stock portfolio.
  • Added to shares of these 7 stocks: IWM (+$255M), XBI (+$223M), SPRO (+$29M), BPMC (+$6.6M), MGTA (+$6.5M), ACIU, GMAB.
  • Started 4 new stock positions in GMAB, ACIU, MGTA, IWM.
  • Reduced shares in these 10 stocks: ARGX (-$7.4M), PIRS, MOR, QURE, ARWR, ANAB, GLPG, DRNA, NGM, RGNX.
  • Sold out of its positions in MOR.
  • Aquilo Capital Management was a net buyer of stock by $498M.
  • Aquilo Capital Management has $945M in assets under management (AUM), dropping by 90.48%.

Tip: Access up to 7 years of quarterly data

Positions held by Aquilo Capital Management, LLC consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Aquilo Capital Management

Companies in the Aquilo Capital Management portfolio as of the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Unit Put Option (XBI) 47.2 $446M +100% 4.0M 111.43
Ishares Tr Russell 2000 Etf Unit Put Option (IWM) 27.0 $255M NEW 1.7M 149.79
Spero Therapeutics (SPRO) 5.3 $50M +131% 4.5M 11.16
Blueprint Medicines (BPMC) 3.8 $36M +22% 386k 92.70
Dicerna Pharmaceuticals (DRNA) 2.6 $25M -5% 1.4M 17.99
Uniqure Nv SHS (QURE) 2.5 $23M -7% 631k 36.83
Arrowhead Pharmaceuticals (ARWR) 2.4 $23M -7% 523k 43.06
Anaptysbio Inc Common (ANAB) 2.3 $22M -7% 1.5M 14.75
Ngm Biopharmaceuticals (NGM) 1.7 $16M -7% 1.0M 15.91
Regenxbio Inc equity us cm (RGNX) 1.5 $14M -7% 511k 27.52
Proqr Thrapeutics N V Shs Euro (PRQR) 1.2 $11M -4% 2.3M 4.79
Pieris Pharmaceuticals (PIRS) 0.8 $7.6M -34% 3.7M 2.07
Magenta Therapeutics (MGTA) 0.7 $6.5M NEW 959k 6.80
Galapagos Nv Spon Adr (GLPG) 0.5 $4.6M -26% 33k 141.91

Setup an alert

Aquilo Capital Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified?

Ac Immune Sa SHS (ACIU) 0.2 $2.3M NEW 464k 4.88
Argenx Se Sponsored Adr (ARGX) 0.2 $2.0M -79% 7.5k 262.53
Genmab A/s Sponsored Ads (GMAB) 0.2 $1.8M NEW 50k 36.62

Past Filings by Aquilo Capital Management

SEC 13F filings are viewable for Aquilo Capital Management going back to 2018